A total of 2839 patients received fixed-dose amlodipine-benazepril, and 3367 received an ACE inhibitor plus a dihydropyridine CCB. Demographic information was not available for the patient population.

Results: Adherence rates among patients receiving fixed-dose amlodipine-benazepril versus an ACE inhibitor plus a dihydropyridine CCB were 87.9% and 69.2%, respectively (p < 0.0001) over a mean ...